Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls

Active, not recruitingOBSERVATIONAL
Enrollment

8,500

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2026

Conditions
Critical IllnessCardiac ArrestSepsisInfluenzaCovid19Trauma
Interventions
DIAGNOSTIC_TEST

Blood collection

Sampling on admission to ICU (all patients)

DIAGNOSTIC_TEST

Blood collection, serial sampling

"Additional sampling to admission samples in~1. the Cardiac Arrest group after 12 and 48 hours~2. the Covid-19 group on day 2 and 7 while in the ICU~3. the Covid-19 group after 3 and 12 months."

Trial Locations (4)

Unknown

Helsingborg Hospital, Helsingborg

Kristianstad Central Hospital, Kristianstad

Skane University Hospital, Lund

Skane University Hospital, Malmo

All Listed Sponsors
collaborator

Region Skane

OTHER

collaborator

Lund University

OTHER

lead

Skane University Hospital

OTHER

NCT04974775 - Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls | Biotech Hunter | Biotech Hunter